Canada's regulatory framework allows generic manufacturers to begin preparing ANDA-equivalent submissions up to 2 years before patent expiration, meaning generic semaglutide could launch in Canada as early as 2029
Kidney Issues : Some individuals may experience renal impairment, particularly those with existing kidney conditions
Diarrhoea is also prevalent with Ozempic, with around 30% of participants experiencing this at least once
The beneficial effects of Bellafill are noticed immediately, and are proven to last 5 years
There were 78 subjects randomized to receive the diabetes drug Lixisenatide and 78 randomized to a placebo
This year, both Eli Lilly and Novo Nordisk have filed several NAD challenges against compounding pharmacies, telehealth companies and medspas marketing compounded versions of semaglutide and tirzepatide